{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:56:28Z","timestamp":1780610188915,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["AI067888"],"award-info":[{"award-number":["AI067888"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["AI092129"],"award-info":[{"award-number":["AI092129"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["11-LABX-0011-01"],"award-info":[{"award-number":["11-LABX-0011-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 de Paris","doi-asserted-by":"publisher","award":["ANR-11-LABX-0011-01"],"award-info":[{"award-number":["ANR-11-LABX-0011-01"]}],"id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.04.065","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T23:09:58Z","timestamp":1588201798000},"page":"4412-4422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant"],"prefix":"10.1016","volume":"38","author":[{"given":"Delia F.","family":"Tifrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukumar","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"le Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Zoonens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"de la Maza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.065_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.04.065_b0010","unstructured":"CDC. Sexually transmitted disease surveillance 2017. In: prevention DoS, editor.: U.S. Department of Health and Human Services. Atlanta; 2018. p. 1\u2013168."},{"key":"10.1016\/j.vaccine.2020.04.065_b0015","series-title":"Trachoma: a blinding scourge from the Bronze Age to the twenty-first century","author":"Taylor","year":"2008"},{"key":"10.1016\/j.vaccine.2020.04.065_b0020","unstructured":"Stamm W. Chlamydia trachomatis infections of the adult. In: Holmes KK, PS, Stamm WE, Piot P, Wasserheit JW, Corey L, Cohen MS, Watts DH, editor. Sexually transmitted diseases. New York: McGrawHill Book Co.; 2008. p. 575\u201393."},{"key":"10.1016\/j.vaccine.2020.04.065_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","article-title":"Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results","volume":"19","author":"Westrom","year":"1992","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2020.04.065_b0030","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.04.065_b0035","first-page":"422","article-title":"Chlamydia trachomatis infection of the Fallopian tubes. Histological findings in two patients","volume":"55","author":"Moller","year":"1979","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.vaccine.2020.04.065_b0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0897.2009.00776.x","article-title":"A multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized koalas (Phascolarctos cinereus): comparison of three different adjuvants","volume":"63","author":"Carey","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/00365540110077001","article-title":"Is the increase in notifications of Chlamydia trachomatis infections in Sweden the result of changes in prevalence, sampling frequency or diagnostic methods?","volume":"34","author":"Gotz","year":"2002","journal-title":"Scandi J Infecti Dis"},{"key":"10.1016\/j.vaccine.2020.04.065_b0050","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.065_b0055","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1016\/j.vaccine.2017.10.075","article-title":"National Institute of Allergy and Infectious Diseases workshop report: \u201cChlamydia vaccines: The way forward\u201d","volume":"37","author":"Zhong","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.065_b0060","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00543-16","article-title":"Update on chlamydia trachomatis vaccinology","volume":"24","author":"de la Maza","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QCO.0000000000000343","article-title":"Future prospects for new vaccines against sexually transmitted infections","volume":"30","author":"Gottlieb","year":"2017","journal-title":"Curr Opin Infect Disc"},{"key":"10.1016\/j.vaccine.2020.04.065_b0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fmicb.2019.00070","article-title":"Seventy years of chlamydia vaccine research - limitations of the past and directions for the future","volume":"10","author":"Phillips","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0075","series-title":"Human chlamydial infections","author":"Schachter","year":"1978"},{"key":"10.1016\/j.vaccine.2020.04.065_b0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1084\/jem.170.4.1271","article-title":"Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein","volume":"170","author":"Morrison","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.04.065_b0085","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1084\/jem.167.3.817","article-title":"High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis","volume":"167","author":"Stephens","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.04.065_b0090","first-page":"892","article-title":"Phylogenetic analysis of the outer-membrane-protein genes of Chlamydiae, and its implication for vaccine development","volume":"10","author":"Fitch","year":"1993","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0264-410X(98)00219-9","article-title":"Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge","volume":"17","author":"Pal","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.065_b0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.175.1.227","article-title":"Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein","volume":"175","author":"Su","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.04.065_b0105","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/IAI.68.6.3074-3078.2000","article-title":"Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses","volume":"68","author":"Dong-Ji","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.065_b0110","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.065_b0115","doi-asserted-by":"crossref","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.065_b0120","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.vaccine.2009.05.008","article-title":"Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.065_b0125","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1128\/JB.00552-07","article-title":"Structural and functional analyses of the major outer membrane protein of Chlamydia trachomatis","volume":"189","author":"Sun","year":"2007","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0130","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1128\/IAI.70.9.4812-4817.2002","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge","volume":"70","author":"Pal","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.065_b0135","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0140","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2011.04.065","article-title":"Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine","volume":"29","author":"Tifrea","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.065_b0145","doi-asserted-by":"crossref","first-page":"15047","DOI":"10.1073\/pnas.93.26.15047","article-title":"Amphipols: polymers that keep membrane proteins soluble in aqueous solutions","volume":"93","author":"Tribet","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2020.04.065_b0150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00232-014-9666-8","article-title":"Amphipols for each season","volume":"247","author":"Zoonens","year":"2014","journal-title":"J Membr Biol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0155","series-title":"Membrane proteins in aqueous solutions: from detergents to amphipols","author":"Popot","year":"2018"},{"key":"10.1016\/j.vaccine.2020.04.065_b0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/14760584.8.3.293","article-title":"Vaccine adjuvants: scientific challenges and strategic initiatives","volume":"8","author":"Harandi","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.04.065_b0165","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.065_b0170","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1021\/acs.biomac.5b01010","article-title":"Synthesis of a polyhistidine-bearing amphipol and its use for immobilizing membrane proteins","volume":"16","author":"Giusti","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.vaccine.2020.04.065_b0175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00232-014-9663-y","article-title":"Functionalized amphipols: a versatile toolbox suitable for applications of membrane proteins in synthetic biology","volume":"247","author":"Della Pia","year":"2014","journal-title":"J Membrane Biol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0180","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1016\/j.vaccine.2018.09.055","article-title":"Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia","volume":"36","author":"Tifrea","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.065_b0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.biochem.052208.114057","article-title":"Amphipols, nanodiscs, and fluorinated surfactants: three nonconventional approaches to studying membrane proteins in aqueous solutions","volume":"79","author":"Popot","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.vaccine.2020.04.065_b0190","doi-asserted-by":"crossref","first-page":"10372","DOI":"10.1021\/la300774d","article-title":"Well-defined critical association concentration and rapid adsorption at the air\/water interface of a short amphiphilic polymer, amphipol A8\u201335: a study by Forster resonance energy transfer and dynamic surface tension measurements","volume":"28","author":"Giusti","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.vaccine.2020.04.065_b0195","doi-asserted-by":"crossref","first-page":"10392","DOI":"10.1021\/bi7007596","article-title":"Dynamics of membrane protein\/amphipol association studied by Forster resonance energy transfer: implications for in vitro studies of amphipol-stabilized membrane proteins","volume":"46","author":"Zoonens","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2020.04.065_b0200","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.4049\/jimmunol.1303392","article-title":"Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum","volume":"192","author":"Tifrea","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00232-014-9690-8","article-title":"Molecular dynamics simulations of a membrane protein\/amphipol complex","volume":"247","author":"Perlmutter","year":"2014","journal-title":"J Membr Biol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0210","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00232-014-9693-5","article-title":"Long-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatis","volume":"247","author":"Feinstein","year":"2014","journal-title":"J Membr Biol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0215","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku250","article-title":"Synthesis of an oligonucleotide-derivatized amphipol and its use to trap and immobilize membrane proteins","volume":"42","author":"Le Bon","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2020.04.065_b0220","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)","volume":"23","author":"Weeratna","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.065_b0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"10.1016\/j.vaccine.2020.04.065_b0230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.01062-12","article-title":"Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis","volume":"81","author":"Massari","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.04.065_b0235","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1128\/JVI.03309-13","article-title":"Toll-like receptor 7\/8 (TLR7\/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques","volume":"88","author":"Moody","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0240","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/cimm.2000.1689","article-title":"Adjuvant activities of immune response modifier R-848: comparison with CpG ODN","volume":"204","author":"Vasilakos","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2020.04.065_b0245","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1016\/j.vaccine.2011.05.013","article-title":"Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine","volume":"29","author":"Carmichael","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.065_b0250","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.addr.2008.12.010","article-title":"The immunogenicity of CpG-antigen conjugates","volume":"61","author":"Wagner","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2020.04.065_b0255","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2020.04.065_b0260","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.176.5.1483","article-title":"Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens","volume":"176","author":"Rawlings","year":"1992","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030582X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030582X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:29Z","timestamp":1759401809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2030582X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":52,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X2030582X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}